🧪 Hypotheses

45 hypotheses generated by SciDEX — searchable by gene, disease, or keyword

45
Total Hypotheses
190
Validated
0.60
Avg Score
0.64
Avg Feasibility

Validated Hypotheses

190 hypotheses have passed validation gates and now form the scientific closure set.

API
All therapeutic (0)mechanistic (45)diagnostic (0)methodological (0)
Sort: ScoreFeasibilityNoveltyImpactNewest
mechanistic 0.89
ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia
🧬 ACSL4 🏥 alzheimers 📖 56🏛 3
✅ 0.75 ✨ 0.85 💥 0.85
## Mechanistic Overview...
mechanistic 0.80
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzheimer's Disease
🧬 ACSL4 🏥 alzheimers 📖 48🏛 4
✅ 0.60 ✨ 0.56 💥 0.00
## Mechanistic Overview...
mechanistic 0.80
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Disease-Associated Microglia
🧬 ACSL4 🏥 alzheimers 📖 45🏛 5
✅ 0.50 ✨ 0.63 💥 0.00
## Mechanistic Overview...
mechanistic 0.78
ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter Degeneration in Alzheimer
🧬 ACSL4 🏥 alzheimers 📖 44🏛 4
✅ 0.60 ✨ 0.54 💥 0.00
## Mechanistic Overview...
mechanistic 0.78
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine in Disease-Associated Microglia
🧬 LPCAT3 🏥 alzheimers 📖 44🏛 4
✅ 0.58 ✨ 0.58 💥 0.00
## Mechanistic Overview...
mechanistic 0.78
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Substrate Pools in Disease-Associated Microglia
🧬 LPCAT3 🏥 alzheimers 📖 43🏛 3
✅ 0.58 ✨ 0.52 💥 0.00
## Mechanistic Overview...
mechanistic 0.77
ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE Peroxidation
🧬 ALOX15 🏥 alzheimers 📖 44🏛 4
✅ 0.50 ✨ 0.62 💥 0.00
## Mechanistic Overview...
mechanistic 0.76
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Disease-Associated Microglia
🧬 LPCAT3 🏥 alzheimers 📖 43🏛 4
✅ 0.63 ✨ 0.51 💥 0.00
## Mechanistic Overview...
mechanistic 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
🧬 TREM2 🏥 alzheimers 📖 30🏛 3
✅ 0.70 ✨ 0.65 💥 0.75
## Mechanistic Overview...
mechanistic 0.75
GFAP-Positive Reactive Astrocyte Subtype Delineation
🧬 GFAP 🏥 alzheimers 📖 32🏛 3
✅ 0.65 ✨ 0.60 💥 0.70
## Mechanistic Overview...
mechanistic 0.75
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate
🧬 C3, C3aR, NFKB1, PPARGC1A 🏥 alzheimers-disease-parkinsons 📖 8🏛 1
✅ 0.50 ✨ 0.50 💥 0.50
## Mechanistic Overview...
mechanistic 0.74
APOE Isoform Expression Across Glial Subtypes
🧬 APOE 🏥 alzheimers 📖 30🏛 3
✅ 0.55 ✨ 0.60 💥 0.60
## Mechanistic Overview...
mechanistic 0.74
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction
🧬 SIRT3 🏥 alzheimers 📖 28🏛 3
✅ 0.65 ✨ 0.70 💥 0.72
## Mechanistic Overview...
mechanistic 0.72
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR Axis for Microglial Metabolic Fitness
🧬 TREM2, TYROBP, SYK, PI3K 🏥 alzheimers 📖 6🏛 3
✅ 0.55 ✨ 0.80 💥 0.73
## Mechanistic Overview...
mechanistic 0.71
TREM2-APOE4 Axis Drives Metabolic Inflexibility in DAM
🧬 TREM2, APOE4, LDHA 🏥 alzheimers 📖 8🏛 1
✅ 0.50 ✨ 0.50 💥 0.50
## Mechanistic Overview...
mechanistic 0.70
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss
🧬 GZMB, PRF1, HLA-E, NKG2D 🏥 alzheimers-disease-parkinsons 📖 5🏛 1
✅ 0.50 ✨ 0.50 💥 0.50
## Mechanistic Overview...
mechanistic 0.68
Complement C1QA Spatial Gradient in Cortical Layers
🧬 C1QA 🏥 alzheimers 📖 10🏛 3
✅ 0.55 ✨ 0.70 💥 0.60
## Mechanistic Overview...
mechanistic 0.67
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
🧬 SLC17A7 🏥 alzheimers 📖 7🏛 3
✅ 0.60 ✨ 0.70 💥 0.65
## Mechanistic Overview...
mechanistic 0.67
C1q-TREM2 Competition for Phosphatidylserine as Pruning Checkpoint
🧬 C1QA, C1QB, TREM2, PSR 🏥 alzheimers 📖 7🏛 1
✅ 0.50 ✨ 0.50 💥 0.50
## Mechanistic Overview...
mechanistic 0.67
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupling
🧬 SLC16A1 🏥 alzheimers 📖 26🏛 3
✅ 0.55 ✨ 0.72 💥 0.60
## Mechanistic Overview...
mechanistic 0.66
Vascular mural cell degeneration precedes and exacerbates parenchymal pathology
🧬 PDGFRB 🏥 alzheimers 📖 9🏛 4
✅ 0.70 ✨ 0.75 💥 0.82
## Mechanistic Overview...
mechanistic 0.66
SPP1+ DAM as Source of Autoimmunity in Neurodegeneration
🧬 SPP1, GALECTIN3, LGALS3, CXCR4 🏥 alzheimers 📖 7🏛 1
✅ 0.50 ✨ 0.50 💥 0.50
## Mechanistic Overview...
mechanistic 0.64
Heterogeneous astrocyte activation states differentially impact neuronal survival across AD progression
🧬 GFAP 🏥 alzheimers 📖 18🏛 3
✅ 0.70 ✨ 0.75 💥 0.82
## Mechanistic Overview...
mechanistic 0.63
Layer V excitatory neurons show selectively enhanced vulnerability through dysregulated calcium signaling
🧬 SLC17A7 🏥 alzheimers 📖 1🏛 4
✅ 0.70 ✨ 0.75 💥 0.82
## Mechanistic Overview...
mechanistic 0.63
Microglial TREM2 downregulation impairs damage-associated response in late-stage Alzheimer's disease
🧬 TREM2 🏥 alzheimers 📖 16🏛 4
✅ 0.70 ✨ 0.75 💥 0.82
## Mechanistic Overview...
mechanistic 0.60
LRP1-Dependent Tau Uptake Disruption
🧬 LRP1 🏥 alzheimers 📖 31🏛 2
✅ 0.46 ✨ 0.40 💥 0.49
**Overview**...
mechanistic 0.60
OPC differentiation blockade contributes to white matter degeneration in early-stage AD
🧬 PDGFRA 🏥 alzheimers 📖 6🏛 3
✅ 0.70 ✨ 0.75 💥 0.82
## Mechanistic Overview...
mechanistic 0.59
VCP-Mediated Autophagy Enhancement
🧬 VCP 🏥 alzheimers 📖 17🏛 2
✅ 0.46 ✨ 0.40 💥 0.50
**Molecular Mechanism and Rationale**...
mechanistic 0.57
APOE4 dual function: beneficial astrocyte anti-inflammatory signaling vs. pathogenic microglial lipid peroxidation
🧬 APOE 🏥 alzheimers 📖 5🏛 1
✅ 0.78 ✨ 0.72 💥 0.00
APOE4's beneficial immune function operates through enhanced astrocyte-mediated lipid metabolism and anti-inflammatory signaling, while its AD risk em...
mechanistic 0.53
Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhibition
🧬 HDAC2 🏥 alzheimers 📖 5🏛 1
✅ 0.78 ✨ 0.68 💥 0.00
Specific butyrate-producing gut bacteria (e.g., Faecalibacterium, Roseburia) generate systemic butyrate that crosses the blood-brain barrier and inhib...
Loading more hypotheses...